IR
TECH icon

Invictus RG’s Bio-Techne TECH Stock Holding History

Invictus RG’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,420
Closed -$431K – 302
2018
Q1 		$431K Sell
11,420
-1,104
-9% -$39K 0.29% 56
2017
Q4 		$406K Buy
12,524
+9,264
+284% +$294K 0.43% 42
2017
Q3 		$99K Buy
+3,260
New +$96.7K 0.09% 293
2016
Q3 		– Sell
-2,048
Closed -$58K – 794
2016
Q2 		$58K Buy
+2,048
New +$52.6K 0.06% 349

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invictus RG's TECH Position: Q2 2018 in Review

Invictus RG sold out of Bio-Techne (TECH) in Q2 2018, closing a stake of 11,420 shares — an estimated $431K sold.

Invictus RG first reported a position in TECH in Q2 2016 and held it in 4 quarters. The position peaked at $431K in Q1 2018. 341 funds tracked by Wall St. Rank hold TECH as of Q2 2018.

  • Invictus RG reported no remaining Bio-Techne position as of Q2 2018 after selling out during the quarter.
  • Invictus RG sold 11,420 Bio-Techne shares in Q2 2018, an estimated $431K.
  • Invictus RG first reported a position in Bio-Techne in Q2 2016 and held it in 4 quarters.
  • Invictus RG's Bio-Techne position peaked at $431K in Q1 2018.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2018.

Based on Invictus RG's 13F filing for Q2 2018, filed 13 Aug 2018.